Bristol-Myers Squibb Global Drug Development
GPTKB entity
Properties (48)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:collaboratesWith |
research institutions
|
| gptkbp:contributedTo |
medical research
patient care healthcare advancements |
| gptkbp:develops |
oncology drugs
immunology drugs cardiovascular drugs virology drugs |
| gptkbp:employs |
scientists
regulatory affairs specialists clinical researchers |
| gptkbp:focusesOn |
drug development
|
| gptkbp:hasAwards |
patient advocacy
excellence in research clinical trial achievements |
| gptkbp:hasFocusOn |
biomarkers
clinical trials patient outcomes precision medicine |
| gptkbp:hasLocalCuisine |
cancer
autoimmune diseases cardiovascular diseases infectious diseases |
| gptkbp:hasParticipatedIn |
gptkb:Asia
gptkb:Latin_America gptkb:North_America Europe Middle_East |
| gptkbp:hasPartnershipsWith |
government agencies
academic institutions biotechnology companies |
| gptkbp:headquarteredIn |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bristol-Myers Squibb Global Drug Development
|
| gptkbp:investmentFocus |
research and development
|
| gptkbp:isInvolvedIn |
safety monitoring
post-marketing studies regulatory submissions drug approvals |
| gptkbp:isPartOf |
drug discovery process
biopharmaceutical industry clinical research community global healthcare system |
| gptkbp:isRecognizedFor |
innovation
quality safety standards |
| gptkbp:operatesIn |
global markets
|
| gptkbp:partOf |
gptkb:Bristol-Myers_Squibb
|